Annual Drug Patent Expirations for NUCYNTA
Nucynta is a drug marketed by Collegium Pharm Inc and is included in three NDAs. It is available from one supplier. There are eight patents protecting this drug and four Paragraph IV challenges.
Drug patent litigation for NUCYNTA.
This drug has seventy-four patent family members in thirty-four countries.
The generic ingredient in NUCYNTA is tapentadol hydrochloride. One supplier is listed for this compound. Additional details are available on the tapentadol hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
